Acknowledgement to Referees.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1149, doi. 10.1007/s40261-019-00874-6
- Publication type:
- Article
Works matching IS 11732563 AND DT 2019 AND VI 39 AND IP 12
Results: 12
1
2
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1195, doi. 10.1007/s40261-019-00849-7
- By:
- Publication type:
- Article
3
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung Cancer
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1153, doi. 10.1007/s40261-019-00859-5
- By:
- Publication type:
- Article
4
Evaluation of the Feasibility of a Web-Based Survey to Assess Patient-Reported Symptom Improvement and Treatment Satisfaction Among Patients with Psoriatic Arthritis Receiving Secukinumab.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1205, doi. 10.1007/s40261-019-00856-8
- By:
- Publication type:
- Article
5
Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1213, doi. 10.1007/s40261-019-00851-z
- By:
- Publication type:
- Article
6
Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1185, doi. 10.1007/s40261-019-00847-9
- By:
- Publication type:
- Article
7
Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1223, doi. 10.1007/s40261-019-00857-7
- By:
- Publication type:
- Article
8
Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient with Metastatic Gastric Adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
9
Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1233, doi. 10.1007/s40261-019-00845-x
- By:
- Publication type:
- Article
10
Non-Vitamin K Antagonist Oral Anticoagulant Treatment in Centenarians: A Series of Four Cases.
- Published in:
- 2019
- By:
- Publication type:
- Letter
11
Investigation of the Association Between Total and Free Plasma and Saliva Mycophenolic Acid Concentrations Following Administration of Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1175, doi. 10.1007/s40261-019-00844-y
- By:
- Publication type:
- Article
12
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1239, doi. 10.1007/s40261-019-00840-2
- By:
- Publication type:
- Article